Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News & Press: Industry News for MS (INforMS)

CMSC INforMS: #CMSC16 –Women with MS Have Significant Depression, Fatigue, Decline in Cognitive

Monday, June 06, 2016  
Posted by: Elizabeth Porco
Share |

Researchers at the University of Arizona studied the psychosocial symptoms felt by a group of female patients with multiple sclerosis (MS) from the southwestern United States, and found significant relationships between depression, fatigue, and cognitive decline — symptoms also related with poorer quality of life and reduced mental and physical health.

The findings suggested that education of healthcare providers about these symptoms may improve MS care, and patients may benefit from self-help intervention programs.

The abstract, titled “Depression, Fatigue, Declines in Cognitive Function, and Uncertainty and Quality of Life Outcomes in Women with Multiple Sclerosis,” was recently presented at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), as part of a session named Psychosocial: Cognition, Depression.

The study included data from more than 200 female MS patients, and the main objectives were the assessment of a possible relationship between depression, fatigue and cognitive decline, and how these symptoms and other factors, such as uncertainty and self-management, influence the quality of life of this particular patient population.

According to the findings, researchers observed significant correlations between depression and fatigue, depression and cognitive function decline, and fatigue and declines in cognitive function. These three symptoms were all found to be significantly related to uncertainty and associated with reduced physical and mental health. Also, depression, fatigue, and decline in cognitive function were found to be significantly associated with a poorer quality of life in female patients.

Researchers stated that such findings point to the existence of a symptom cluster in MS of depression, fatigue, and cognitive function decline and recommended establishing an intervention aimed at educating health providers for the three symptoms.

The research team also suggested that MS patients might benefit from the development of a self-help program. “A research study including a larger population of women with MS located throughout the United States, and not just the southwest, is necessary before any education aimed at health-care professionals or individuals with MS is developed or implemented,” the researchers concluded.

MS is an autoimmune disease characterized by chronic damage in the central nervous system. It is the most prevalent neurologic disease among young and middle-aged adults and, although it does not always negatively affect life expectancy, it is associated with healthcare costs of $10 billion annually.

By Margarida Azevedo

Multiple Sclerosis News Today

CMSC Disclaimer 
The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.


Sign In


Forgot your password?

Haven't registered yet?

Latest News
Upcoming Events

10/27/2016 » 10/29/2016
2016 International Symposium: The Multiple Sclerosis Brain – Bridging the Gap

3 University Plaza Drive, Suite 116
Hackensack, NJ 07601
Tel: 201-487-1050 | Fax: 862-772-7275
Privacy Policy | Disclaimer